User Fees Should Recognize Complete Product Life Cycle - FDA's Feigal
This article was originally published in The Tan Sheet
Executive Summary
The design of FDA's user fee system should encourage attention to the entire life cycle of a product, Center for Devices & Radiologic Health Director David Feigal, MD, said at the Food & Drug Law Institute meeting in Washington, D.C. June 5.